11 January 2023 | News
Indegene is leveraging life sciences services and healthcare solutions across the commercialization value chain in Germany and across Europe.
Photo Credit: Freepik
India’s Bangalore based Indegene, a digital-first, life sciences commercialization company, has launched a new center in Germany, expanding its client-focused consulting and management team in the region.
Indegene will use this center to accelerate the digital transformation of life sciences companies throughout their commercialization value chain in Europe. Indegene is leveraging life sciences services and healthcare solutions across the commercialization value chain in Germany and across Europe. Indegene already has a significant presence in Europe, with centers in the UK, Ireland, and Switzerland.
Manish Gupta, Chairman and CEO, Indegene said “Our investment in Germany reiterates our continued commitment to the region. With this new center, we will co-innovate and collaborate with clients more effectively and help accelerate their digital journey.”
Indegene supports many leading clients in the region in a variety of ways “Over the last 3 years, Indegene has helped us transform our go-to-market operations and enable better physician and patient engagement via more agile, data-driven, omnichannel ways. Their life sciences domain expertise and digital-first approach are helping us improve time to market” said Dr. Michael Kurr, Global Head of Go-to-Market Services, Boehringer Ingelheim.
With six operation hubs and 16 offices located across North America, Europe, and Asia, Indegene’s client base includes 19 of the 20 largest biopharmaceutical companies, many emerging biotech companies, and medical device companies.